Morphology and immunohistochemistry of rat aortic grafts

Folia Microbiologica

Volumn 44, Issue 3, 1999, Pages 339-353

  Rossmann, P ^a   Lacha J ^b   Lodererova A ^b  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

ABDOMINAL AORTA; ALLOTRANSPLANTATION; ANIMAL; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; ISOGRAFT; LEWIS RAT; MALE; PATHOLOGY; RAT; REVIEW; TRANSPLANTATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, ABDOMINAL; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0033252462     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02818558     Document Type: Review

References (49)

1. ADAMS D.H., WYNER L.R., KARNOVSKY M.J.: Experimental graft atherosclerosis. Transplantation 56, 794-799 (1993).
2. ANDERSON H.D., HOLM P., SENDER S. et al.: Relative importance of ischemic injury and immunological injury on the development of transplant atherosclerosis in rabbit aortic allografts. Transplantation 60, 631-638 (1995).
3. AZUMA H., BINDER J., HEEMANN U. et al.: Effects of RS 61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 59, 460-466 (1995).
4. COLVIN R.B.: The pathogenesis of vascular rejection. Transplant.Proc. 23, 2052-2055 (1991)
5. DEMETRIS A.J., ZERBE T., BANNER B.: Morphology of solid organ allograft arteriopathy. Transplant.Proc. 21, 3667-3670 (1989).
6. DENNIS M.J.S., BECKINGHAM I.J., BLAMEY R.W.: Evaluation of animal models of chronic vascular rejection. Transplant.Proc. 25, 2102-2103 (1993).
7. FELLSTRÖM B., LARSSON E., TUFVESON G.: Strategies in chronic rejection of transplanted organs - a current view on pathogenesis, diagnosis and treatment. Transplant.Proc. 21, 1435-1439 (1989).
8. FELLSTRÖM B.C., LARSSON E.: Pathogenesis and treatment perspectives of chronic rejection. Immunol.Rev. 134, 84-98 (1993).
9. FOEGH M.L., RAMWELL P.W.: Angiopeptin - experimental and clinical studies of inhibition of myointimal proliferation. Kidney Internat. 48 (Suppl.), 18-22 (1995).
10. GEERLING R.A., DE BRUIJN R.W.F., SCHERINGA M. et al.: Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat. Transplantation 58, 1258-1263 (1994).
11. GERLACH C., GOLDING M., LARUE L. et al.: Ki-67 immunoexpression is a robust marker of proliferative cells in the rat. Lab.Invest. 77, 697-698 (1997).
12. GOHRA H., MCDONALD T.O., VEDRRIER E.D., AZIZ S.: Endothelial loss and regeneration in a model of transplant arteriosclerosis. Transplantation 60, 96-102 (1995).
13. GONZALEZ Z.E., VERMEULEN F., EHRENFELD W.K.: Relations between circulating blood and pathogenesis of atherosclerosis. Israel J.Med.Sci. 5, 648-651 (1969).
14. HANCOCK W.W.: Basic science aspects of chronic rejection - induction of protective genes to prevent development of transplant arteriosclerosis. Transplant.Proc. 30, 1585-1589 (1998).
15. HANSSON G.K.: Cytokines regulate proliferation and cytoskeletal organization of vascular smooth muscle cells. Path.Res.Pract. 190, 891-894 (1994).
16. HÄYRY P., ISONIEMI H., YILMAZ S. et al.: Chronic allograft rejection. Immunol.Rev. 134, 33-81 (1993).
17. HÄYRY P.: Pathophysiology of chronic rejection. Transplant.Proc. 28 (Suppl), 7-10 (1996).
18. HÄYRY P., MYLLÄRNIEMI M., AAVIK E. et al.: Role of growth factors in graft vessel disease. Transplant.Proc. 29, 2551-2552 (1997).
19. HÄYRY P.: Common pathways in allograft arteriosclerosis and experimental vascular injury - inflammation. Transplant.Proc. 30, 685-686 (1998).
20. HOWIE A.J., BRYAN R.L., GUNSON B.K.: Arteries and veins formed within renal vessels - a previously neglected observation. Virchows Arch.Path.Anat. 420, 301-304 (1992).
21. JENKINS J., BOYLE J.J., MCPHADEN A.R., LINDOP G.B.M.: Three-dimensional reconstruction of abnormal intramural chronic arteries in human heart allograft biopsies. J.Pathol. 181, 247-250 (1997).
22. JONASSON L., HOLM J., HANSSON G.K.: Smooth muscle cells express Ia antigens during arterial response to injury. Lab.Invest. 58, 310-315 (1988).
23. KOSKINEN P.K., LEMSTRÖM K.B., HÄYRY P.: How cyclosporin modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Amer.J.Pathol. 146, 972-980 (1995).
24. LÁCHA J., LEHMANN M., CHADIMOVÁ M. et al.: Effect of anti-CD4 monoclonal antibody and cyclosporin A or a combination of both on chronic rejection in the rat aortic allograft model. Transplant.Proc. 26, 3242-3243 (1994)
25. LI F., YIN M., VAN DAM J.G.: Cytomegalovirus infection enhances the neointima formation in rat aortic allografts. Transplantation 65, 1298-1304 (1998).
26. MAGGARD M.M., KE B., WANG T.: Effects of Pravastatin on chronic rejection of rat heart allografts. Transplantation 65, 149-155 (1998).
27. MCDONALD P.C., KENYON J.A., MCMANUS B.M.: The role of lipids in transplant vascular disease. Lab.Invest. 78, 1187-1201 (1998).
28. MCGRATH J.A., EADY R.A.J.: Heparan-sulphate proteoglycan and wound healing in skin J.Pathol. 183, 251-252 (1997).
29. MENNANDER A., TIISALA S., HALTTUNEN J. et. al.: Chronic rejection in rat aorta allografts - an experimental model for transplant arteriosclerosis. Arterioscl.&.Thromb. 11, 671-680 (1991).
30. MOTOMURA N., LOU H., ORSKOV H. et al.: Exposure of vascular allografts to IGF-1 increases vascular expression of IGF-1 ligand and receptor protein, and accelerates arteriosclerosis in rats. Transplantation 65, 1024-1030 (1998).
31. PROUDFOOT D., SHANAHAN C.M., WEISSBERG P.L.: Vascular calcification - new insights into an old problem. J.Pathol. 185, 1-3 (1998).
32. ROSSMANN P., JIRKA J.: Rejection Nephropathy. Elsevier-North-Holland, Amsterdam, and Academia Publishers, Prague, 1979.
33. ROSSMANN P., JIRKA J., CHADIMOVÁ M. et al.: Arteriosclerosis of the human renal allografts - morphology, origin, life history and relationship to cyclosporin therapy. Virchows Arch.Path.Anat. 418, 129-141 (1991).
34. ROSSMANN P., JIRKA J., MATOUŠOVIC K.: Renal Allograft Biopsy - Image, Interpretation, Interventions. Academia Publishers, Prague 1997.
35. ROSSMANN P., JIRKA J., MATOUŠOVIC K.: Immunohistochemistry of renal allograft biopsies. (In Czech) Čas.Lék.Čes. 137, 757-762 (1998).
36. ROSSMANN P., ŘIHOVÁ B., STROHALM J., ULBRICH K.: Morphology of rat kidney and thymus after native and antibody-coupled cyclosporin A application (reduced toxicity of targeted drug). Folia Microbiol. 42, 277-287 (1997).
37. RUSSELL M.E., FUJITA M., MASEK M.A.: Cardiac graft vascular disease - nonselective involvement of large and small vessels. Transplantation 56, 1599-1601 (1993).
38. RYFFEL B., SIEGEL H., PETRIC R. et al.: Nephrotoxicity of cyclosporin in spontaneously hypertensive rats - effects on blood pressure and vascular lesions. Clin.Nephrol. 25 (Suppl.), 193-198 (1986).
39. SCHMID C., HEEMANN V., TILNEY N.L.: Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection. Transplantation 61, 1695-1699 (1996).
40. SCHNITZ-RIXEN T., MEGERMAN J., COLVIN R.B. et al.: Immunosuppressive treatment of aortic allografts. J.Vasc.Surg. 7, 82-92 (1988).
41. SCHWARTZ R.S.: Neointima and arterial injury: dogs, rats, pigs and more. Lab.Invest. 71, 789-791 (1994).
42. SOLEZ K., AXELSEN R.A., BENEDIKTSSON H. et al.: International standardization for the histologic diagnosis of renal allograft rejection - the Banff working classification of kidney transplant pathology. Kidney Internat. 44, 411-422 (1993).
43. SUBRAMANIAN S.V., OROSZ C.G., STRANCH A.R.: Vascular smooth muscle cell alpha actin as an indicator of parenchymal cell reprogrammmg in heart allografts. Transplantation 65, 1652-1656 (1998).
44. TANABE S., UEDA M., HAN Y.S. et al.: Enhanced fibronectin expression is associated with the development of graft arteriosclerosis in human renal allografts. Transplant.Proc. 27, 1078-1081 (1995).
45. TILNEY N.L., WHITLEY W.D.W., DIAMOND J.R. et al.: Chrome rejection - an undefined conundrum. Transplantation 52, 389-398 (1991).
46. VANRENTERGHEM Y.: The use of mycophenolate - Mofetil in renal transplantation. Nephron 76, 392-399 (1997).
47. WILHELM M.J., KUSAKA M., PRATSCHKE J., TILNEY N.L.: Chrome rejection - increasing evidence for the importance of allogen-independent factors. Transplant.Proc. 30, 2402-2406 (1998).
48. XIAO F., CHONG A., SHEN J. et al.: Pharmacologically induced regression of chronic transplant rejection. Transplantation 60, 1065-1072 (1995).
49. YILMAZ S., HÄYRY P.: The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 56, 1153-1156 (1993).